Valuation, investment, M&A and fundamental trends in aesthetics
M&A and trends in aesthetics
Key Figures
| Total cumulated value | Average 18-24 / NO. Transactions per year | Total Disclosed Deals Value in Medical Aesthetics 2023 | Average Sales Multiples 2023 | Average EBITDA Multiples 2023 |
| $120bn | 54 | $7.0bn | 4.6x | 18.5x |
PURPOSE OF THE STUDY
This report aims to provide comprehensive insights into the major transactions and trends of 2023, focusing on mergers and acquisitions and partnership activities in the broad sector of aesthetics that includes Medical Aesthetics, Dermal Fillers, Toxins, Tissular Inductors, EBD, Dermocosmetics OTC, RX skincare, Regenerative Medicine, and Aesthetic Clinics. As such, this reports includes market data, valuation multiples, deal values, transaction case studies, strategic analysis, licensing and M&A deal overviews in the sectors.
It offers an overview of current megatrends and explores the prospects for 2024, highlighting the growing momentum that suggests a strong year ahead. Additionally, the report looks ahead to upcoming megatrends for 2024-2025.
The primary purpose of this study is to furnish stakeholders, including industry leaders, investors, and policymakers, with an in-depth financial and investment analysis of the aesthetics market. It seeks to uncover the driving forces behind the market’s expansion, understand the challenges and constraints faced by the sector, and identify the opportunities for future growth. By evaluating market dynamics, consumer behavior, and competitive strategies, the report intends to aid in strategic decision-making, external growth strategies and offer forecasts that help in planning long-term growth strategies in the aesthetics industry.
GEOGRAPHICAL DISTRIBUTION
- NORTH AMERICA leads the market in terms of target deal volume with 39%, followed by Europe with 35%
- In terms of buyer’s activities, EUROPE holds 50% of the disclosed M&A transactions in medical aesthetics in 2023.
GROWING TREND
- Bioactive treatments
- Previsualization and digitalization
- High-density dermal fillers
KEY CHALLENGES
- REGULATORY HURDLES: More stringent in Europe and heterogeneity of global regulations increase barriers to entry.
- SPECIFIC LOCAL DEMAND: high need for strategy adaptation among very diverse demands and specificity of different skin types, body morphologies, beauty standards requires strong partnerships, R&D flexibility and smart marketing.
KEY OPPORTUNITIES
- More people seek “reverse-aging” solutions and body contouring, expanding service offerings towards regenerative medicine, and new types of biopolymers
- Investment in high quality standards as the new key differentiator and development of new products and formulations
CONTACT FOR ENQUIRIES AND QUOTES: fpuchly@windome-banking.com
